Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126361962 | 12636196 | 2 | F | 20160720 | 20160818 | 20160809 | 20160826 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-47719BP | BOEHRINGER INGELHEIM | 61.28 | YR | F | Y | 0.00000 | 20160827 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126361962 | 12636196 | 1 | PS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 18 MCG | 508089B,15C3219 | 21395 | 18 | UG | INHALATION POWDER, HARD CAPSULE | QD | |||||
| 126361962 | 12636196 | 2 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 40 MG | 0 | 40 | MG | TABLET | QD | ||||||
| 126361962 | 12636196 | 3 | C | COREG | CARVEDILOL | 1 | Oral | 0 | TABLET | ||||||||||
| 126361962 | 12636196 | 4 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG | 0 | 81 | MG | TABLET | QD | ||||||
| 126361962 | 12636196 | 5 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 2 ANZ | 0 | CAPSULE | BID | ||||||||
| 126361962 | 12636196 | 6 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | STRENGTH: 5 MG / 325 MG | 0 | TABLET | |||||||||
| 126361962 | 12636196 | 7 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126361962 | 12636196 | 8 | C | NITROGLYCERIN. | NITROGLYCERIN | 1 | Oral | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126361962 | 12636196 | 1 | Chronic obstructive pulmonary disease |
| 126361962 | 12636196 | 2 | Blood cholesterol increased |
| 126361962 | 12636196 | 3 | Cardiac operation |
| 126361962 | 12636196 | 4 | Cardiac operation |
| 126361962 | 12636196 | 5 | Muscle twitching |
| 126361962 | 12636196 | 6 | Pain |
| 126361962 | 12636196 | 7 | Bursitis |
| 126361962 | 12636196 | 8 | Chest pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126361962 | 12636196 | Dizziness | |
| 126361962 | 12636196 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126361962 | 12636196 | 1 | 201604 | 0 | ||
| 126361962 | 12636196 | 3 | 2011 | 0 | ||
| 126361962 | 12636196 | 4 | 2011 | 0 |